Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefpirome and Moxifloxacin PK in Abscess Fluid
NCT00280514Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2006
- Primary completion
- Dec 2009
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefpirome and moxifloxacin in abscess and Abdominal cyst, sponsored by Medical University of Vienna. Primary endpoint: Area Under the Curve at 8 hours. Started Jan 2006; status: completed.
02
Drugs
cefpiromemoxifloxacin
03
Conditions
abscessAbdominal cyst
Beyond the preview
Go deeper on NCT00280514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280514.